Study by Kong et al. [63] investigating the mechanism through which the GWAS identified CDKN2A/2B variants increase the T2D risk showed the impact of CDKN2A/2B SNPs mediated through β-cell mass but not β-cell function. Here, CDKN2A is linked to type 2 diabetes mellitus.